SONITU Pharmaceuticals is a biopharmaceutical company
utilizing innovative target-based approach to design and discover novel drug candidates that can be developed as novel treatments for cancer and diabetes. Innovative target-based technologies combine biology and
chemistry to enable efficient discovery of new compounds that may serve as potential treatments for cancer, diabetes and other diseases. The firm's chemistry-based approach is to modify existing compounds to discover new drug candidates. More specifically, the firm uses database searches to identify pharmacophore groups to design new drug candidates.
